Related Experiment Video
Updated: Jan 7, 2026

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
REACT-UTI: A 72-Hour Composite to Predict Early Non-Response and Length of Stay in Hospitalized Adults with Lower
Adela Benea1,2, Lavinia Stelea3, Mirela Turaiche2
1Doctoral School, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.
Abstract:
Background and Objectives: Early bedside tools that flag non-response in hospitalized adults with lower urinary tract infection (UTI) could align clinical care with antimicrobial stewardship. We evaluated REACT-UTI, a 72 h composite combining C-reactive protein (CRP) clearance ≥35%, defervescence (temperature < 37.5 °C), and ≥2-point symptom improvement, to predict early non-response and hospital length of stay (LOS), and we assessed modifiable processes of care. Methods: We conducted a prospective observational study of adults with culture-confirmed lower UTI (n = 126) admitted to a tertiary hospital in Timișoara (December 2023-August 2025). The primary outcome was 72 h early clinical response (ECR) defined by REACT-UTI. Multivariable logistic regression examined associations of catheter-associated UTI (CAUTI), time-to-effective therapy, baseline CRP, diabetes, early catheter removal/exchange (≤48 h), and early intravenous-to-oral switch (≤72 h) with non-response. Results: Overall, 76/126 patients (60.3%) achieved ECR. Non-responders more often had CAUTI, higher baseline CRP, longer time-to-effective therapy, ESBL or fluoroquinolone-resistant Enterobacterales, and longer LOS (14.1 vs. 9.8 days; p < 0.001). Adjusted models showed that CAUTI, delayed active therapy, higher baseline CRP, and diabetes increased the odds of non-response, whereas early catheter removal (adjusted odds ratio [aOR] 0.5, 95% confidence interval [CI] 0.3-0.9) and early IV-to-oral switch (aOR 0.4, 0.2-0.8) were protective. Greater CRP clearance correlated with shorter LOS (ρ = -0.52; p < 0.001). Conclusions: In this single-center setting with a high burden of antimicrobial resistance, REACT-UTI at 72 h identified patients at risk of early non-response and prolonged hospitalization and highlighted actionable levers-timely active therapy, catheter management, and early oral step-down. External validation in diverse settings is needed before broader implementation.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Infection IV: Nursing Management
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management

